{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:48:27Z","timestamp":1782247707953,"version":"3.54.5"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite novel breakthroughs in the inflammatory bowel disease (IBD) therapeutics armamentarium, nonadherence remains an invisible epidemic. However, its prevalence and determining features were unknown within resource-strained healthcare settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A hospital-based cross-sectional study was conducted on adults with IBD from December 2023 to July 2024. A standardized questionnaire and medical record review checklist were used to gather data. Multiple ordinal logistic regression analysis was used to adjudicate potential covariates. A variable was deemed statistically significant if its adjusted odds ratio had a\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value of below 0.05 at 95% confidence interval.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study comprised 237 patient cohort (age: mean \u00b1 SD, 53.81\u2005\u00b1\u20056.71 years). Among them, 32.9, 29.96, and 37.14% were low, medium, and high adherents, respectively. Just under half (43.05%) of participants had a high medication regimen complexity score (mean \u00b1 SD, 19.46\u2005\u00b1\u20052.11). Health insurance status, active disease state, medication regimen complexity score, stigma, comorbidity status, adverse drug reactions, and polypharmacy were the potential predictors identified in the final model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Nearly two-thirds of the study\u2019s cohort exhibited suboptimal medication adherence, highlighting a significant clinical concern. Policymakers could consider developing key strategies such as integrating pharmacists and Medication Regimen Complexity Index-65 into IBD chronic care, and leveraging a validated, local-language adherence assessment tool offer a powerful approach to optimize treatment adherence among IBD sufferers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/meg.0000000000003166","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:00:54Z","timestamp":1774285254000},"page":"916-924","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Medication adherence level and its predictors among inflammatory bowel disease sufferers in a resource-strained healthcare setting"],"prefix":"10.1097","volume":"38","author":[{"given":"Woretaw S.","family":"Zewdu","sequence":"first","affiliation":[{"name":"Pharmacology and Toxicology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigabu E.","family":"Zerihun","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemen A.","family":"Emiru","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, College of Health Sciences, Debre Tabor University, Debre Tabor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B.","family":"Dagnew","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilaye A.","family":"Moges","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn A.","family":"Mussie","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yared A.","family":"Ferede","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisay S.","family":"Anberbr","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Birhan University, Debre Birhan, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muluken A.","family":"Alemu","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teferi B.","family":"Melese","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel T.","family":"Kassaw","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"R1-20260623","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases.","volume":"383","author":"Longo","year":"2020","journal-title":"N Engl J Med"},{"key":"R2-20260623","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","article-title":"Crohn\u2019s disease.","volume":"403","author":"Dolinger","year":"2024","journal-title":"Lancet"},{"key":"R3-20260623","doi-asserted-by":"crossref","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019.","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"R4-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-024-04711-x","article-title":"Global, regional, and national burden of inflammatory bowel disease, 1990\u20132021: insights from the Global Burden of Disease 2021.","volume":"39","author":"Lin","year":"2024","journal-title":"Int J Colorectal Dis"},{"key":"R5-20260623","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/inthealth\/ihaa005","article-title":"Inflammatory bowel disease in Africa: what is the current state of knowledge?","volume":"12","author":"Hodges","year":"2020","journal-title":"Int Health"},{"key":"R6-20260623","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease.","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20260623","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R8-20260623","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.14309\/01.ajg.0000860060.39523.7f","article-title":"Inflamatory bowel disease in sub-Saharan Africa setting: experience from a large teritiary center in Ethiopia.","volume":"117","author":"Fekade","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R9-20260623","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis.","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"R10-20260623","doi-asserted-by":"crossref","first-page":"e100006","DOI":"10.1136\/egastro-2023-100006","article-title":"Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directions.","volume":"2","author":"Little","year":"2024","journal-title":"eGastroenterology"},{"key":"R11-20260623","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.2147\/PPA.S424024","article-title":"What do we know about medication adherence interventions in inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis? A scoping review of randomised controlled trials.","volume":"17","author":"King","year":"2023","journal-title":"Patient Prefer Adherence"},{"key":"R12-20260623","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ajg.2009.685","article-title":"Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review.","volume":"105","author":"Jackson","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R13-20260623","doi-asserted-by":"crossref","first-page":"i2219","DOI":"10.1093\/ecco-jcc\/jjad212.1389","article-title":"Exploration of medication non-adherence in inflammatory bowel disease patients: a systematic review.","volume":"18","author":"King","year":"2024","journal-title":"J Crohns Colitis"},{"key":"R14-20260623","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ueg2.12547","article-title":"Difficult-to-treat inflammatory bowel disease: effectiveness and safety of 4th and 5th lines of treatment.","volume":"12","author":"Caron","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"R15-20260623","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11739-019-02268-0","article-title":"Stigmatisation and resilience in inflammatory bowel disease.","volume":"15","author":"Lenti","year":"2020","journal-title":"Intern Emerg Med"},{"key":"R16-20260623","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/healthcare11040474","article-title":"Enacted stigma in inflammatory bowel disease: an Italian phenomenological study.","volume":"11","author":"Simeone","year":"2023","journal-title":"Healthcare"},{"key":"R17-20260623","first-page":"1","article-title":"Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008.","volume":"42","author":"Gu","year":"2010","journal-title":"NCHS Data Brief"},{"key":"R18-20260623","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S2468-1253(22)00047-4","article-title":"Inflammatory bowel disease in sub-Saharan Africa: epidemiology, risk factors, and challenges in diagnosis.","volume":"7","author":"Watermeyer","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R19-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562848231184986","article-title":"Challenges in the diagnosis and management of IBD: a sub-Saharan African perspective.","volume":"16","author":"Watermeyer","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"R20-20260623","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10620-022-07675-6","article-title":"Crohn\u2019s disease among the poorest billion: burden of Crohn\u2019s disease in low- and lower-middle-income countries.","volume":"68","author":"Rajbhandari","year":"2023","journal-title":"Dig Dis Sci"},{"key":"R21-20260623","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/ijpp\/riad063","article-title":"Clinical pharmacists\u2019 perspective of medication adherence support in Ethiopian hospital settings: a qualitative study.","volume":"31","author":"Tegegn","year":"2023","journal-title":"Int. J. Pharm. Pract"},{"key":"R23-20260623","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","article-title":"Development validation of the medication regimen complexity index.","volume":"38","author":"George","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R24-20260623","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/phar.1452","article-title":"Validation of a patient-level medication regimen complexity index as a possible tool to identify patients for medication therapy management intervention.","volume":"34","author":"Hirsch","year":"2014","journal-title":"Pharmacotherapy"},{"key":"R25-20260623","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","article-title":"Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses.","volume":"42","author":"Thompson","year":"2000","journal-title":"Schizophr Res"},{"key":"R26-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12991-023-00472-z","article-title":"Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study.","volume":"23","author":"Kiflu","year":"2024","journal-title":"Ann Gen Psychiatry"},{"key":"R27-20260623","doi-asserted-by":"crossref","first-page":"e0277796","DOI":"10.1371\/journal.pone.0277796","article-title":"Adherence to anti-asthma medications among adult asthmatic patients in Eastern Ethiopia: a multi-center cross-sectional study.","volume":"17","author":"Heluf","year":"2022","journal-title":"PLoS One"},{"key":"R28-20260623","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00408-024-00746-7","article-title":"Factors associated with corticosteroid adherence in sarcoidosis.","volume":"202","author":"Judson","year":"2024","journal-title":"Lung"},{"key":"R29-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-024-03884-1","article-title":"Randomized comparison of the effects of tailored text messaging versus pillbox organizers on medication adherence of heart failure patients.","volume":"24","author":"FarzanehRad","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"R30-20260623","doi-asserted-by":"crossref","first-page":"3652855","DOI":"10.1155\/2024\/3652855","article-title":"Patients\u2019 perceptions and knowledge of diabetes and medications: implications for medication adherence and glycemic control in type 2 diabetes patients, Northern Ethiopia.","volume":"2024","author":"Hadush","year":"2024","journal-title":"J Diabetes Res"},{"key":"R31-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562848221144088","article-title":"Medication adherence in women with IBD of childbearing age likely associated with disease knowledge.","volume":"15","author":"Laube","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"R32-20260623","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index.","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"R33-20260623","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(80)92858-5","article-title":"A simple index of Crohn\u2019s-disease activity.","volume":"315","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"R34-20260623","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jgh3.12537","article-title":"Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic.","volume":"5","author":"Barnes","year":"2021","journal-title":"JGH Open"},{"key":"R35-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2024.1369569","article-title":"Medication regimen complexity and its impact on medication adherence in patients with multimorbidity at a comprehensive specialized hospital in Ethiopia.","volume":"11","author":"Kassaw","year":"2024","journal-title":"Front Med"},{"key":"R36-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-022-00089-1","article-title":"Medication regimen complexity and its impact on medication adherence and asthma control among patients with asthma in Ethiopian referral hospitals.","volume":"8","author":"Belachew","year":"2022","journal-title":"Asthma Res Pract"},{"key":"R37-20260623","doi-asserted-by":"crossref","first-page":"e000685","DOI":"10.1136\/bmjdrc-2019-000685","article-title":"Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.","volume":"7","author":"Ayele","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R38-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/1744472","article-title":"Exploring the impact of medication regimen complexity on health-related quality of life in patients with multimorbidity.","volume":"2023","author":"Gebresillassie","year":"2023","journal-title":"J Clin Pharm Ther"},{"key":"R40-20260623","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1060028016673652","article-title":"Medication regimen complexity and A1C goal attainment in underserved adults with type 2 diabetes: a cross-sectional study.","volume":"51","author":"Yeh","year":"2017","journal-title":"Ann Pharmacother"},{"key":"R41-20260623","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10865-012-9422-4","article-title":"Development and psychometric evaluation of the Chronic Illness Anticipated Stigma Scale.","volume":"36","author":"Earnshaw","year":"2013","journal-title":"J Behav Med"},{"key":"R42-20260623","doi-asserted-by":"crossref","first-page":"e0262744","DOI":"10.1371\/journal.pone.0262744","article-title":"Translation and psychometric evaluation of chronic illness anticipated stigma scale (CIASS) among patients in Ethiopia.","volume":"17","author":"Salih","year":"2022","journal-title":"PLoS One"},{"key":"R43-20260623","doi-asserted-by":"crossref","first-page":"e0273734","DOI":"10.1371\/journal.pone.0273734","article-title":"Anticipated stigma and associated factors among chronic illness patients in Amhara Region Referral Hospitals, Ethiopia: a multicenter cross-sectional study.","volume":"17","author":"Salih","year":"2022","journal-title":"PLoS One"},{"key":"R44-20260623","doi-asserted-by":"crossref","first-page":"e0283994","DOI":"10.1371\/journal.pone.0283994","article-title":"Level of shared decision making and associated factors among patients with mental illness in Northwest Ethiopia: explanatory sequential mixed method study.","volume":"18","author":"Abate","year":"2023","journal-title":"PLoS One"},{"key":"R45-20260623","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.2147\/IJGM.S359082","article-title":"Medication adherence and its influencing factors among inflammatory bowel disease patients in China.","volume":"15","author":"Xu","year":"2022","journal-title":"Int J Gen Med"},{"key":"R46-20260623","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ibd\/izac051","article-title":"Psychological factors associated with adherence to oral treatment in ulcerative colitis.","volume":"29","author":"Dasharathy","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"R47-20260623","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/MIB.0000000000001201","article-title":"Clinical predictors of future nonadherence in inflammatory bowel disease.","volume":"23","author":"Severs","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"R48-20260623","doi-asserted-by":"crossref","first-page":"102850","DOI":"10.1016\/j.eclinm.2024.102850","article-title":"Designing for medication adherence in inflammatory bowel disease: multi-disciplinary approaches for self-administrable biotherapeutics.","volume":"77","author":"Feig","year":"2024","journal-title":"eClinicalMedicine"},{"key":"R49-20260623","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/MCG.0000000000001647","article-title":"Polypharmacy in patients with inflammatory bowel disease: prevalence and outcomes in a single-center series.","volume":"56","author":"Mesonero","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"R50-20260623","doi-asserted-by":"crossref","first-page":"844","DOI":"10.14309\/ajg.0000000000003036","article-title":"Severe polypharmacy increases risk of hospitalization among older adults with inflammatory bowel disease.","volume":"120","author":"Drittel","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"R51-20260623","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s10620-023-08250-3","article-title":"Prevalence and appropriateness of polypharmacy in older adults with inflammatory bowel diseases.","volume":"69","author":"Kochar","year":"2024","journal-title":"Dig Dis Sci"},{"key":"R52-20260623","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40264-021-01045-3","article-title":"Adverse drug reactions from real-world data in inflammatory bowel disease patients in the IBDREAM registry.","volume":"44","author":"Giraud","year":"2021","journal-title":"Drug Saf"},{"key":"R53-20260623","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MCG.0b013e31802f19af","article-title":"Patient subjective assessment of drug side effects in inflammatory bowel disease.","volume":"42","author":"Cross","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R54-20260623","first-page":"1","article-title":"Impact of patient engagement on healthcare quality: a scoping review.","volume":"9","author":"Marzban","year":"2022","journal-title":"J Patient Exp"},{"key":"R55-20260623","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/MCG.0000000000001480","article-title":"Impact of demographic, clinical and psychosocial variables on drug adherence and outcomes in Indian patients with inflammatory bowel disease: cost is not the only factor!","volume":"55","author":"Banerjee","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"R56-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-024-05016-y","article-title":"Investigating the association between medication regimen complexity, medication adherence and treatment satisfaction among Malaysian older adult patients: a cross-sectional study.","volume":"24","author":"Al Haqimy Mohammad Yunus","year":"2024","journal-title":"BMC Geriatr"},{"key":"R57-20260623","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/MEG.0000000000000704","article-title":"Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.","volume":"28","author":"Campos","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R58-20260623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/4060648","article-title":"Treatment adherence in inflammatory bowel disease patients from Argentina: a multicenter study.","volume":"2020","author":"Lasa","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"R59-20260623","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/1751-2980.12539","article-title":"Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting.","volume":"18","author":"Martelli","year":"2017","journal-title":"J Dig Dis"},{"key":"R60-20260623","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5217\/ir.2018.00033","article-title":"Medication non-adherence in inflammatory bowel diseases is associated with disability.","volume":"16","author":"Perry","year":"2018","journal-title":"Intest Res"},{"key":"R61-20260623","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ajg.2017.438","article-title":"Defining an optimal adherence threshold for patients taking subcutaneous anti-TNFs for inflammatory bowel diseases.","volume":"113","author":"Govani","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R62-20260623","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/jgh.13155","article-title":"Patients\u2019 beliefs and attitudes about their treatment for inflammatory bowel disease in Korea.","volume":"31","author":"Kim","year":"2016","journal-title":"J Gastroenterol Hepatol"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:01:42Z","timestamp":1782244902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000003166","relation":{},"ISSN":["0954-691X","1473-5687"],"issn-type":[{"value":"0954-691X","type":"print"},{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"2025-08-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}